首页 | 本学科首页   官方微博 | 高级检索  
     


Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene
Authors:Christian Balmer  Diana Ballhausen  Nils U. Bosshard  Beat Steinmann  Eugen Boltshauser  Urs Bauersfeld  Andrea Superti-Furga
Affiliation:(1) Department of Paediatric Cardiology, University Children"rsquo"s Hospital, Steinwiesstrasse 75, 8032 Zurich, Switzerland;(2) Division of Metabolism and Molecular Paediatrics, University Children"rsquo"s Hospital, Zurich, Switzerland;(3) Division of Neurology, University Children"rsquo"s Hospital, Zurich, Switzerland;(4) Division of Molecular Paediatrics, University Hospital Lausanne (CHUV), Lausanne, Switzerland
Abstract:A boy presented at age 2.5 years with mild left ventricular hypertrophy and mild myopathy. Hypertrophic cardiomyopathy progressed relentlessly, leading to death at age 16 years shortly before planned heart transplantation. During the course of the disease, his mother developed severe dilated cardiomyopathy and died of its complications at 46 years of age. The combination of myopathy and cardiomyopathy, the biochemical and electron microscopy findings in a muscle biopsy, and the pedigree suggested Danon disease (MIM 300257), an X-linked lysosomal storage disorder caused by deficiency of lysosome-associated membrane protein-2 (LAMP2). The diagnosis was confirmed by the identification of a novel mutation, G138A, in the LAMP2gene, leading to the premature stop codon W46X. Conclusion:Early diagnosis of Danon disease is important for genetic counselling and timely cardiac transplantation, the only effective therapeutic option.
Keywords:Danon disease  Glycogen storage disease with normal acid maltase  LAMP2 deficiency  Lysosomal membrane  X-linked vacuolar cardiomyopathy and myopathy
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号